Delegation of Authority, 50379 [2018-21672]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 194 / Friday, October 5, 2018 / Notices
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2018–21688 Filed 10–4–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Delegation of Authority
Notice is hereby given that I have
delegated to the Director, National
Institute for Occupational Safety and
Health (NIOSH), Centers for Disease
Control and Prevention (CDC), without
authority to redelegate, the authority
vested in the Director, CDC, under
Section 2695, Title XXVI of the Public
Health Service Act (42 U.S.C. 300ff–
131), and the Ryan White HIV/AIDS
Treatment Extension Act of 2009 (Pub.
L. 111–87), as amended.
This delegation became effective on
August 27, 2018. I hereby affirm and
ratify any actions taken that involve the
exercise of the authorities delegated
herein prior to the effective date of this
delegation.
Dated: October 1, 2018.
Robert R. Redfield,
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2018–21672 Filed 10–4–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–1704–N]
Medicare Program; Town Hall Meeting
on the FY 2020 Applications for New
Medical Services and Technologies
Add-On Payments
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice of meeting.
AGENCY:
This notice announces a
Town Hall meeting in accordance with
section 1886(d)(5)(K)(viii) of the Social
Security Act (the Act) to discuss fiscal
year (FY) 2020 applications for add-on
payments for new medical services and
technologies under the hospital
inpatient prospective payment system
(IPPS). Interested parties are invited to
this meeting to present their comments,
daltland on DSKBBV9HB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:11 Oct 04, 2018
Jkt 247001
recommendations, and data regarding
whether the FY 2020 new medical
services and technologies applications
meet the substantial clinical
improvement criterion.
DATES:
Meeting Date: The Town Hall Meeting
announced in this notice will be held on
Tuesday, December 4, 2018. The Town
Hall Meeting will begin at 9:00 a.m.
Eastern Standard Time (e.s.t.) and
check-in will begin at 8:30 a.m. e.s.t.
Deadline for Registration for
Participants (not Presenting) at the
Town Hall Meeting: The deadline to
register to attend the Town Hall Meeting
is 5:00 p.m., e.s.t. on Monday,
November 26, 2018.
Deadline for Requesting Special
Accommodations: The deadline to
submit requests for special
accommodations is 5:00 p.m., e.s.t. on
Monday, November 19, 2018.
Deadline for Registration of Presenters
at the Town Hall Meeting: The deadline
to register to present at the Town Hall
Meeting is 5:00 p.m., e.s.t. on Monday,
November 19, 2018.
Deadline for Submission of Agenda
Item(s) or Written Comments for the
Town Hall Meeting: Written comments
and agenda items for discussion at the
Town Hall Meeting, including agenda
items by presenters, must be received by
5:00 p.m. e.s.t. on Monday, November
19, 2018.
Deadline for Submission of Written
Comments after the Town Hall Meeting
for consideration in the FY 2020 IPPS
proposed rule: Individuals may submit
written comments after the Town Hall
Meeting, as specified in the ADDRESSES
section of this notice, on whether the
service or technology represents a
substantial clinical improvement. These
comments must be received by 5:00
p.m. e.s.t. on Friday, December 14,
2018, for consideration in the FY 2020
IPPS proposed rule.
ADDRESSES: Meeting Location: The
Town Hall Meeting will be held in the
main Auditorium in the central building
of the Centers for Medicare & Medicaid
Services located at 7500 Security
Boulevard, Baltimore, MD 21244–1850.
In addition, we are providing two
alternatives to attending the meeting in
person—(1) there will be an open tollfree phone line to call into the Town
Hall Meeting; or (2) participants may
view and participate in the Town Hall
Meeting via live stream technology or
webinar. These options are discussed in
section II.B. of this notice.
Registration and Special
Accommodations: Individuals wishing
to participate in the meeting must
register by following the on-line
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
50379
registration instructions located in
section III. of this notice or by
contacting staff listed in the FOR
FURTHER INFORMATION CONTACT section of
this notice. Individuals who need
special accommodations should contact
staff listed in the FOR FURTHER
INFORMATION CONTACT section of this
notice.
Submission of Agenda Item(s) or
Written Comments for the Town Hall
Meeting: Each presenter must submit an
agenda item(s) regarding whether a FY
2020 application meets the substantial
clinical improvement criterion. Agenda
items, written comments, questions or
other statements must not exceed three
single-spaced typed pages and may be
sent via email to newtech@cms.hhs.gov.
FOR FURTHER INFORMATION CONTACT:
Michelle Joshua, (410) 786–6050,
michelle.joshua@cms.hhs.gov; or
Michael Treitel, (410) 786–4552,
michael.treitel@cms.hhs.gov.
Alternatively, you may forward your
requests via email to newtech@
cms.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background on the Add-On Payments
for New Medical Services and
Technologies Under the IPPS
Sections 1886(d)(5)(K) and (L) of the
Social Security Act (the Act) require the
Secretary to establish a process of
identifying and ensuring adequate
payments to acute care hospitals for
new medical services and technologies
under Medicare. Effective for discharges
beginning on or after October 1, 2001,
section 1886(d)(5)(K)(i) of the Act
requires the Secretary to establish (after
notice and opportunity for public
comment) a mechanism to recognize the
costs of new services and technologies
under the hospital inpatient prospective
payment system (IPPS). In addition,
section 1886(d)(5)(K)(vi) of the Act
specifies that a medical service or
technology will be considered ‘‘new’’ if
it meets criteria established by the
Secretary (after notice and opportunity
for public comment). (See the fiscal year
(FY) 2002 IPPS proposed rule (66 FR
22693, May 4, 2001) and final rule (66
FR 46912, September 7, 2001) for a more
detailed discussion.)
In the September 7, 2001 final rule (66
FR 46914), we noted that we evaluated
a request for special payment for a new
medical service or technology against
the following criteria in order to
determine if the new technology meets
the substantial clinical improvement
requirement:
• The device offers a treatment option
for a patient population unresponsive
E:\FR\FM\05OCN1.SGM
05OCN1
]]>Agencies
[Federal Register Volume 83, Number 194 (Friday, October 5, 2018)]
[Notices]
[Page 50379]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-21672]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Delegation of Authority
Notice is hereby given that I have delegated to the Director,
National Institute for Occupational Safety and Health (NIOSH), Centers
for Disease Control and Prevention (CDC), without authority to
redelegate, the authority vested in the Director, CDC, under Section
2695, Title XXVI of the Public Health Service Act (42 U.S.C. 300ff-
131), and the Ryan White HIV/AIDS Treatment Extension Act of 2009 (Pub.
L. 111-87), as amended.
This delegation became effective on August 27, 2018. I hereby
affirm and ratify any actions taken that involve the exercise of the
authorities delegated herein prior to the effective date of this
delegation.
Dated: October 1, 2018.
Robert R. Redfield,
Director, Centers for Disease Control and Prevention.
[FR Doc. 2018-21672 Filed 10-4-18; 8:45 am]
BILLING CODE 4163-18-P
